|
THUNDER BAY, ONTARIO--(Marketwired - June 11, 2014) - Benton Capital Corp. (TSX VENTURE:BTC) ("Benton" or the "Company") is pleased to provide a further update to its April 14, 2014 news release wherein it announced that it had signed a binding letter of intent ("LOI") to acquire a 100% interest in Folium Life Science Inc. ("Folium"), a private medical marijuana company, with its head office located in Abbotsford, British Columbia (the "Transaction"). |
